Search
Patexia Research
Case number 1:22-cv-00089

Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al > Summary

Court Case Number 1:22-cv-00089

Filing Date Sep 9, 2022

Termination Date Mar 7, 2023

Court West Virginia Northern District Court

Status Dismissed - Other

JudgesChief District Thomas S. Kleeh, Chief Thomas S. Kleeh

Plaintiff

2

Otsuka Pharmaceutical

H. Lundbeck A/S

Defendant

Viatris Inc.

Related Patents

Doc No Title Issue date
11344547 Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function May 31, 2022
11154553 Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function Oct 26, 2021
10980803 Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function Apr 20, 2021
10525057 Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function Jan 7, 2020
08722679 Controlled release sterile injectable aripiprazole formulation and method May 13, 2014
08399469 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof Mar 19, 2013
08338427 Methods for administering aripiprazole Dec 25, 2012
08030313 Controlled release sterile injectable aripiprazole formulation and method Oct 4, 2011
07807680 Controlled release sterile injectable aripiprazole formulation and method Oct 5, 2010
Menu